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Catheter ablation of atrial fibrillation (AF) is one of the most complex interventional procedures in cardiology. The pro-
cedure has been associated with a minimal but nevertheless 
important risk of major complications.1–5 Cardiac tamponade is 
the most frequently encountered  procedure-related complication 
occurring in 1.2% to 1.3% of patients in 2 worldwide surveys2,6 
and 1.3% in a European survey.7 It is also the main cause of pro-
cedure-related mortality, responsible for 25% of lethal cases.8,9
Editorial see p 195 
Clinical Perspective on p 280
Female sex is a known risk factor for complications during 
AF ablation.1,3,4,10 In a study of 40 patients who developed 
cardiac tamponade during AF ablation at 3 institutions,11 
half of the patients were women, despite the known lower 
prevalence of women undergoing AF ablation.12 In con-
trast in a series of 3265 patients (16% women) undergoing 
AF ablation, women did not experience more tampon-
ade.10 Higher cardiac perforation risk was also observed in 
women undergoing percutaneous coronary interventions,13 
devices implantations,14 and catheter ablation of accessory 
pathways.15
© 2014 American Heart Association, Inc.
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Original Article
Background—Cardiac tamponade is the most dramatic complication observed during atrial fibrillation (AF) ablation and 
the leading cause of procedure-related mortality. Female sex is a known risk factor for complications during AF ablation; 
however, it is unknown whether women have a higher risk of tamponade.
Methods and Results—A systematic Medline search was used to locate academic electrophysiological centers that reported 
cases of tamponade occurring during AF ablation. Centers were asked to provide information on cases of acute tamponade 
according to sex and their mode of management including any case of related mortality. Nineteen electrophysiological 
centers provided information on 34 943 ablation procedures involving 25 261 (72%) men. Overall, 289 (0.9%) cases of 
tamponade were reported: 120 (1.24%) in women and 169 (0.67%) in men (odds ratio, 1.83; P<0.001). There was a 
reciprocal association between center volume and the occurrence of tamponade with substantially lower risk in high-
volume centers. Most cases of tamponade occurred during catheter manipulation or ablation; women tended to develop 
more tamponades during transseptal catheterization. No sex difference in the mode of management was observed. 
However, 16% cases of tamponade required surgery with lower rates in high-volume centers. Three cases of tamponade 
(1%) culminated in death.
Conclusions—Tamponade during AF ablation procedures is relatively rare. Women have an ≈2-fold higher risk for 
developing this complication. The risk of tamponade among women decreases substantially in high-volume centers. 
Surgical backup and acute management skills for treating tamponade are important in centers performing AF ablation.  
(Circ Arrhythm Electrophysiol. 2014;7:274-280.)
Key Words: atrial fibrillation ◼ cardiac tamponade ◼ catheter ablation ◼ sex
Received June 12, 2013; accepted January 20, 2014.
The Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/doi:10.1161/CIRCEP.113.000760/-/DC1.
Correspondence to Bernard Belhassen, MD, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Weizman St 6, Tel-Aviv 64239, Israel. 
E-mail bblhass@tasmc.health.gov.il
Effects of Sex on the Incidence of Cardiac Tamponade 
After Catheter Ablation of Atrial Fibrillation
Results From a Worldwide Survey in 34 943 Atrial Fibrillation  
Ablation Procedures
Yoav Michowitz, MD; Michael Rahkovich, MD; Hakan Oral, MD; Erica S. Zado, PA-C;  
Roland Tilz, MD; Silke John, MD; Arnaud Denis, MD; Luigi Di Biase, MD;  
Roger A. Winkle, MD; Evgeny N. Mikhaylov, MD, PhD; Jeremy N. Ruskin, MD; Yan Yao, MD;  
Mark E. Josephson, MD; Hildegard Tanner, MD; John M. Miller, MD; Jean Champagne, MD;  
Paolo Della Bella, MD; Koichiro Kumagai, MD; Pascal Defaye, MD; David Luria, MD;  
Dmitry S. Lebedev, MD, PhD; Andrea Natale, MD; Pierre Jais, MD; Gerhard Hindricks, MD;  
Karl-Heinz Kuck, MD; Francis E. Marchlinski, MD; Fred Morady, MD; Bernard Belhassen, MD
 at Universitaet Bern on July 17, 2014http://circep.ahajournals.org/Downloaded from 
Michowitz et al  Sex and Tamponade After AF Ablation  275
The purpose of the present study was to evaluate the rela-
tionship between patient sex and cardiac tamponade in a large 
patient cohort undergoing catheter ablation of AF.
Methods
Data Source and Center Selection
A Medline search was used to locate academic electrophysiological 
centers that are involved in AF ablation. The systematic Medline re-
view was conducted by 2 investigators with the typed search words 
atrial fibrillation ablation. The search was limited to English language 
articles published between 2000 and 2012 that involved only patients 
aged >19 years. All centers with publications reporting tamponade as 
a procedure complication were eligible for inclusion.
Meta-analyses, multicenter trials, and case reports were excluded, as 
well as publications that involved patients with AF with associated car-
diomyopathies, valvular heart disease, or uncommon cardiac anatomy 
or those who underwent surgical ablation of AF. Studies that involved 
the use of Hansen or Stereotaxis for catheter manipulation or high-in-
tensity focused ultrasound as the source of energy were also excluded.
Data Acquisition
All electrophysiological center directors were contacted and asked 
to provide detailed information on (1) the total number of AF abla-
tion procedures performed in their laboratory; (2) the total number of 
procedures performed in patients of each sex; (3) the total number of 
acute tamponade occurring during or within 24 hours after the pro-
cedure in regard to patient sex; (4) the age of patients experiencing 
tamponade; (5) the mode of management of tamponade (pericardio-
centesis, surgery, or both); and (6) any case of 30-day mortality that 
was assumed to result from tamponade.
The cooperating centers were also asked about (1) the use of intracar-
diac echocardiography (ICE) or transesophageal echocardiography for 
transseptal puncture and monitoring pericardial space; (2) the average 
power settings during AF ablation they used; and (3) the mode occurrence 
of tamponade according to patient sex: during transseptal puncture, cath-
eter manipulation, or ablation in the left atrium. The study was approved 
by the Tel-Aviv Medical Center institutional review committee.
Statistical Analysis
All data were summarized as number and percent in each center. The 
calculation of the combined effect size was done as a  meta-analysis. 
At the first step, a heterogeneity test was done, followed by the 
calculation of the fixed and random combined effect size using 
DerSimonian and Laird method,16 and the results were displayed as 
a forest plot.
The estimation of the association between the center experience and 
the percent of tamponade was done using regression curve estimation 
for inverse association (y=a+ b/x). We assumed that the responses 
from centers were representative and that nonresponse bias was neg-
ligible. All analyses were considered significant at P<0.05 (2-sided). 
Categorical data were analyzed using the χ2 test. The Comprehensive 
Meta-analysis software was used for the meta-analysis (http://www.
meta-analysis.com/index.php), whereas all other analyses were per-
formed using the SPSS software version 21.0 (2012).
Results
Medline Search
The search permitted retrieval of 2740 citations. After review-
ing all abstracts and when necessary the full articles we iden-
tified 136 reports from 85 electrophysiological centers that 
were compatible with the inclusion criteria.
Overall 19 centers provided details of their entire AF abla-
tion patient cohort, whereas 2 (#16 and #17) that provided a 
large number of patients only gave data on selective consecutive 
years (Table 1). Ten centers provided data on the occurrence of 
tamponade in the study group described in their published report 
but not in their entire AF ablation cohort. Therefore, these cen-
ters were not included in the present study. In 6 instances the cor-
responding authors could not be located. Authors from 3 centers 
responded but could not provide the requested data. Forty-seven 
electrophysiological centers did not answer our e-mails.
Study Patient Cohort
Overall, 34 943 AF ablation procedures were conducted in the 
19 participating centers: 25 261 (72%) in men and 9682 (28%) 
in women. There were 289 (0.84%) cases of acute tamponade 
of which 169 (0.67%) occurred in men and 120 (1.24%) in 
women (P<0.0001). The distribution of procedures and tam-
ponade among the various centers is provided in Table 1, with 
Q value of 17.3 in the heterogeneity test (P=0.50). The aver-
age age of men with tamponade was 62±9 years (range, 32–83 
years; median, 62) was comparable with that of women, 63±9 
years (range, 21–82 years; median 64; P=0.16).
An odds ratio plot is provided in Figure 1, demonstrating an 
overall 83% higher risk (odds of 1.83) for women to develop 
tamponade during AF ablation. Individually in 17 of 19 cen-
ters there was a higher proportion of women who experienced 
tamponade; however, the sex difference reached statistical sig-
nificance (P<0.05) in only 5 centers.
Analysis According to Center Procedural Volume
A regression curve demonstrating the relationship between 
center volume and tamponade percentage is provided in 
Figure 2. A reciprocal relationship forces the curve to flat-
ten out >1500 with an asymptotic value of 0.45%. Analyzing 
men and women separately (Figure 3) shows similar regres-
sion lines. In men, the incidence of tamponade decreases 
from 0.73% (for 1000 patients) to 0.45% (for n=∞ patients), 
whereas in women the incidence of tamponade decreases 
from 0.87% (for 1000 patients) to 0.5% (for n=∞ patients).
Procedural Characteristics Related to Tamponade
Eighteen of 19 (95%) centers provided detailed information about 
procedural characteristics related to tamponade in 279 patients. 
The use of ICE or transesophageal echocardiography for transsep-
tal puncture and monitoring pericardial space was systematic in 6 
electrophysiological centers (#6, 9, 11, 13, 14, and 18), whereas it 
was not used in 9 (2–5, 8, 10, 15–17). Center #7 used ICE in the 
vast majority of cases but in none of the tamponade cases. Center 
#19 used ICE in >60% of cases, whereas the remaining centers 
started to use ICE/transesophageal echocardiography routinely 
only recently (#1) or as needed (#12). Power settings were not 
significantly different between centers, ranging from 20 to 35 W 
in the posterior wall and ≤40 W elsewhere. Lesion duration varied 
from 15 to 60 seconds and temperature <42 to 45°C. Center #13 
used 50 W during ablation, however, with continuous movement. 
Center #3 also used cryoballoon. Ten cases of tamponade were 
related to discernible steam pops (1 center reported the occurrence 
of steam pops without the development of tamponade). Forty-
three tamponades (27 men [16.5%], 16 women [13.7%]; P=0.6) 
were diagnosed post procedurally.
Of a total of 279 tamponades (116 women) reported in 
the 18 electrophysiological centers, presumed mechanism 
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of tamponade was related to radiofrequency energy delivery 
in the left atrium, unknown, catheter manipulation, or trans-
septal puncture in 33.3%, 32.9%, 22.9%, and 10.8% patients, 
respectively (Table I in the Data Supplement). Women tended 
to develop more tamponades during transseptal catheteriza-
tion (16.3% versus 6.7%; P=0.046).
Mode of Tamponade Management
Of the 289 cases of tamponade reported by the 19 participat-
ing centers, 243 (84%) were treated by pericardiocentesis 
only, 43 (15%) by pericardiocentesis followed by surgery, and 
3 (1%) by surgery-only (Table 2). All 3 patients treated by 
surgery-only were women. There was no sex difference in the 
percentage of patients managed by surgery (P=0.125). There 
was an inverse correlation between the proportions of patients 
with tamponade treated by surgery and the center procedural 
volume (r=−0.466; R2=0.217; P=0.044; Figure 4).
Tamponade-Related Mortality
There were 3 death events (1%) among the 289 cases of car-
diac tamponade. Mortality rate resulting from tamponade was 
0.008% for all procedures. The 3 lethal cases occurred in dif-
ferent centers and involved men only. One case of tamponade 
was identified several hours after the procedure with no evi-
dence of pericardial effusion on ICE at the end of the proce-
dure. The other 2 were diagnosed in the electrophysiological 
laboratory. All tamponade-related deaths occurred a few days 
after the procedure.
Discussion
Main Findings
To the best of our knowledge this is the largest study evaluat-
ing sex difference in the risk of tamponade during AF ablation. 
The occurrence of tamponade during AF ablation procedures 
was found to be relatively rare (0.84%); however, women had 
an 83% higher risk for developing this complication. The risk 
of developing tamponade was inversely related to center vol-
ume with a substantial decrease in women risk in high-volume 
centers. Surgical management was required in 16% of cases of 
tamponade irrespective of patient sex, whereas 1% of cases of 
tamponade resulted in death.
Sex and Risk of Tamponade
Patel et al10 examined 3265 patients who underwent AF abla-
tion, of whom 518 (16%) were women. They did not report 
any sex difference in tamponade occurrence; however, the 
overall incidence of tamponade was extremely low (0.3%), 
and therefore that study was underpowered to answer 
the question.
Shah et al1 reported the outcomes of 4156 AF ablations iden-
tified from a California state database. They reported a 2.5% 
incidence of tamponade. Although female sex was associ-
ated with increased complication risk, the individual associa-
tion of female sex and tamponade was not reported. A higher 
periprocedural complication risk among women was also 
reported in several other studies3,4,17 that suggested increased 
caution and preprocedural discussion of anticipated risk in 
women.4 Nevertheless, all the above-referenced studies were 
Table 1.  Study Patient Cohort and Incidence of Cardiac Tamponade Among the Participating Centers
Institution
Total No. of 
Procedures
Total No. of 
Tamponades Tamponades, %
Total No. of 
Procedures 
in Men
Total No. of 
Procedures 
in Women
Tamponade 
in Men
Tamponade 
in Women
No. % No. %
1 264 6 2.27 183 81 1 0.55 5 6.17
2 264 11 4.17 187 77 7 3.74 4 5.19
3 429 7 1.63 334 95 4 1.20 3 3.16
4 857 6 0.70 637 220 4 0.63 2 0.91
5 893 12 1.34 641 252 10 1.56 2 0.79
6 990 8 0.81 841 149 4 0.48 4 2.68
7 1020 20 1.96 616 404 6 0.97 14 3.47
8 1067 10 0.94 818 249 6 0.73 4 1.61
9 1117 21 1.88 809 308 10 1.24 11 3.57
10 1267 15 1.18 876 391 8 0.91 7 1.79
11 1376 10 0.73 975 401 6 0.62 4 1.00
12 1432 15 1.05 808 624 4 0.50 11 1.76
13 1504 9 0.60 1083 421 5 0.46 4 0.95
14 2751 6 0.22 1946 805 4 0.21 2 0.25
15 2923 19 0.65 2349 574 14 0.60 5 0.87
16 3356 24 0.72 2210 1146 13 0.50 11 1.13
17 3498 24 0.69 2344 1154 14 0.60 10 0.87
18 4259 24 0.56 3315 944 19 0.57 5 0.53
19 5676 42 0.74 4289 1387 30 0.70 12 0.87
Total 34 943 289 0.83 25 261 9682 169 0.67 120 1.24
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underpowered to estimate the direct association of sex and 
tamponade.
Two large worldwide surveys on AF ablation by Cappato 
et al2,6 in 11 762 and 20 825 ablation procedures found tam-
ponade to be the most common acute complication in 1.2% 
and 1.3% of patients, respectively. An European survey7 and 
a survey among Medicare beneficiaries18 found tampon-
ade rates of 1.3% and 1.7%, respectively. However, none of 
these surveys2,6,7,18 provided data on sex-related complication 
differences. In our study, the tamponade rate (0.84%) was 
lower than that found in worldwide and European surveys. 
This could be explained by the lower median center volume, 
at least for the world surveys2,6 (37 and 275, respectively), as 
compared with 1267 in our present study.
Interestingly, our results demonstrate that the rate of tampon-
ade decreases and is similar after 1000 procedures in men and 
women (0.87% and 0.73%, respectively). However, because 
only 25% to 30% of AF ablation procedures (28% in the current 
study) are performed in women,12 only centers with total proce-
dural volume of 1390 reach this figure in men compared with 
centers with procedural volume of 3570 who reach it in women.
Procedural Characteristics Related to Tamponade
The lower occurrence of tamponade in high-volume centers is 
unlikely to be related to different procedural routines among 
the participating centers. Power settings were overall similar 
and ICE/transesophageal echocardiography was not used in 
the majority of centers, including several high-volume centers 
with low event rates. Of note, few cases of tamponade were 
preceded by steam pops. Most cases of tamponade (56.2%) 
were presumably related to catheter manipulation in the left 
atrium or catheter ablation without sex difference. However, 
women tended to develop more tamponades during transseptal 
catheterization. Whether this may be related to a higher inci-
dence of atrial septal aneurysm among women19 that may ren-
der transseptal puncture more difficult and thereby increases 
the tamponade risk deserves further study. The mechanism of 
Figure 2. Association between center volume and the risk of 
tamponade. A reciprocal regression is shown (tamponade rate, 
0.45% at n=∞, R2=0.713).
Figure 1. Odds ratio for women compared with men to develop tamponade during atrial fibrillation ablation, among the 19 participating 
centers, presented as a meta-analysis; combined odds ratio 1.83, P<0.001. CI indicates confidence interval.
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higher tamponade risk among women was not explored in the 
present study. Another possible explanation for increased tam-
ponade risk in women may include thinner left atrial wall and 
lower atrial volume (which is related to a lower body surface 
area), especially in patients with AF.20,21
Mode of Management of Tamponade
Our study is the first to report the need for surgery for manag-
ing cardiac tamponade in a large-scale multicenter survey, as 
other reports on the mode of treatment of tamponade originate 
from smaller single or multicenter series.5,11,22
Most cases of tamponade were successfully handled by peri-
cardiocentesis; however, in 16% of cases, surgery was required. 
In most instances surgery was preceded by pericardiocentesis. In 
only a minority of cases, surgery was the initial mode of treatment. 
Again, our results demonstrate that in high-volume centers the 
percentage of patients requiring surgery was lower. Nevertheless, 
a curve plot of center volume and the need for surgery dem-
onstrate a non-negligible 10% incidence of patients requiring 
surgery even in centers performing >4000 ablation procedures. 
Based on our present results and in agreement with the recent 
conclusions of the international Expert Consensus Statement on 
Catheter and Surgical Ablation of Atrial Fibrillation,23 we think 
that centers performing AF ablation should have skill in acute 
tamponade management including pericardiocentesis and on-
site surgical backup. In our study, only 1% of patients died as a 
consequence of tamponade, and this relatively low incidence rate 
could be related to the fact that all participating institutions were 
academic centers with surgical facilities. In contrast, a recent sur-
vey of German centers performing AF ablation showed that only 
44% of electrophysiological centers performing AF ablation had 
in-house surgical backup.24
Mortality
In a summarizing analysis of their 2 worldwide surveys, Cap-
pato et al8 reported an incidence of 0.07% mortality during AF 
procedures. The most frequent cause of mortality was tampon-
ade (responsible for 25% of deaths) and it occurred in 2% cases 
of tamponade. In our study, we found a lower incidence of 1% 
mortality in direct relation with tamponade. As for tamponade, 
this lower rate of mortality could be related to a larger mean 
center volume in our study. Also, as stated above, all institutions 
participating in our survey had surgical facilities. In contrast, 
the study of Cappato et al8 did not provide information on the 
availability of surgical backup for the patients who died because 
of tamponade, precluding the possibility of further elaborating 
the role of such backup in a course lethal to their patients.
Limitations
Participation in our survey was voluntary and the response rate 
of contributing centers (22%) was relatively low. However, it 
was similar to that obtained by Cappato et al2,6 in their surveys 
(24% and 20%, respectively). If nonresponse bias is large then 
the reported results need not be significant. Thus, the results 
while credible require further confirmation. In addition, we 
cannot assume how many nonrespondent centers were large 
or small centers.
The present study involved many highly skilled academic 
institutions and therefore the quality of the findings may 
not be representative of the general population of patients 
undergoing AF ablation. Moreover, an inherent limitation of 
surveys is the self-selection involved in response. This may 
explain the lower rate of tamponade documented in our study 
as compared with that observed in the Medicare survey18 and 
previous reports.2,6,7
Figure 3. Upper, Reciprocal regression lines demonstrating the association between center volume and risk of tamponade among men 
R2=0.355 and women R2=0.718. The lines are shown in a similar scale to simplify comparison. Lower, Estimated tamponade percentage 
using the fitted curves at n=1000, 1250, 1500, and ∞ procedures.
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Nevertheless, according to our results, we anticipate that 
the rates of cardiac tamponade and that of tamponade requir-
ing surgery or culminating in death will be even higher in less 
experienced centers, especially in women.
As this is a large-scale multicenter study we could only 
gather limited individual patients’ characteristics. Therefore, 
we were unable to evaluate the potential role of individual 
operator experience and learning curves and distinguish the 
role of sex from that of associated confounding covariates that 
may likely be more frequently observed in women (ie, smaller 
left atrial size, heart size, and body mass index).
Finally, our study focus was on acute cardiac tamponade. 
It is known that tamponade occurrence and presentation after 
AF ablation may be delayed ≤45 days.25
Conclusions
This large-scale multicenter survey provides evidence for an 
 ≈2-fold higher risk of tamponade during AF ablation procedures 
among women. Yet, the rate of tamponade is low among skilled 
academic centers. Both sex difference and center experience 
should be taken in account when obtaining informed patient 
consent before the procedure. In addition, the availability of 
immediate surgical backup is advised as a sizable percentage 
of patients with tamponade may require surgical intervention.
Disclosures
None.
Appendix
From the Department of Cardiology, Tel Aviv Sourasky Medical Center, 
Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (Y.M., 
M.R., B.B.); Division of Cardiology, University of Michigan Medical 
Center, Ann Arbor (H.O., F.M.); Cardiovascular Division, Department of 
Medicine, Hospital of the University of Pennsylvania, Philadelphia (E.S.Z., 
F.E.M.); Asklepios Klinik St. Georg, Hamburg, Germany (R.T., K.-H.K.); 
Department of Electrophysiology, Leipzig Heart Center, Leipzig University, 
Leipzig, Germany (S.J., G.H.); Hôpital Cardiologique du Haut Lévêque, 
Service de Rythmologie, Bordeaux, France (A.D., P.J.); Texas Cardiac 
Arrhythmia Institute, St. David's Medical Center, Austin, TX (L.D.B.); 
Department of Biomedical Engineering, University of Texas, Austin (L.D.B., 
A.N.); Silicon Valley Cardiology, E Palo Alto, CA (R.A.W.); Department 
of Electrophysiology and Cardiac Pacing, Almazov Federal Heart, Blood, 
and Endocrinology Centre, Saint-Petersburg, Russian Federation (E.N.M., 
D.S.L.); Cardiac Arrhythmia Service, Massachusetts General Hospital 
(J.N.R.) and Department of Medicine, Cardiovascular Division, Beth Israel 
Deaconess Medical Center (M.E.J.), Harvard Medical School, Boston, MA; 
Division One, Department of Cardiology, Fuwai Hospital, Peking Union 
Medical College, Chinese Academy of Medical Sciences, Beijing, China 
(Y.Y.); Department of Cardiology, Inselspital, University Hospital and 
University of Bern, Bern, Switzerland (H.T.); Krannert Institute of Cardiology, 
Indiana University Hospital, Indianapolis (J.M.M.); Institut Universitaire de 
Cardiologie et Pneumologie de Québec, Quebec City, Quebec, Canada (J.C.); 
Arrhythmia Unit and EP Laboratories, Ospedale San Raffaele, University 
of Milan, Milan, Italy (P.D.B.); Heart Rhythm Center, Fukuoka Sanno 
Hospital, Fukuoka, Japan (K.K.); Arrhythmia Unit, Cardiology Department, 
University Hospital, Grenoble, France (P.D.); and Cardiac Electrophysiology 
Laboratory, Sheba Medical Center, Ramat-Gan, Israel (D.L.).
References
 1. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural 
complications, rehospitalizations, and repeat procedures after catheter ab-
lation for atrial fibrillation. J Am Coll Cardiol. 2012;59:143–149.
 2. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, 
Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated 
worldwide survey on the methods, efficacy, and safety of catheter ablation 
for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32–38.
 3. Hoyt H, Bhonsale A, Chilukuri K, Alhumaid F, Needleman M, Edwards 
D, Govil A, Nazarian S, Cheng A, Henrikson CA, Sinha S, Marine JE, 
Berger R, Calkins H, Spragg DD. Complications arising from catheter ab-
lation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 
2011;8:1869–1874.
 4. Spragg DD, Dalal D, Cheema A, Scherr D, Chilukuri K, Cheng A, 
Henrikson CA, Marine JE, Berger RD, Dong J, Calkins H. Complications 
of catheter ablation for atrial fibrillation: incidence and predictors. 
J Cardiovasc Electrophysiol. 2008;19:627–631.
 5. Bertaglia E, Zoppo F, Tondo C, Colella A, Mantovan R, Senatore G, 
Bottoni N, Carreras G, Corò L, Turco P, Mantica M, Stabile G. Early 
Table 2.  Cases of Tamponade Managed by Surgery Among the 
Participating Centers
Institution Tamponade
Surgery, 
n (%)
Tamponade 
Men
Surgery 
Men,  
n (%)
Tamponade 
Women
Surgery  
Women, 
n (%)
1 6 2 (33) 1 0 (0) 5 2 (40)
2 11 2 (18) 7 2 (29) 4 0 (0)
3 7 2 (28) 4 2 (50) 3 0 (0)
4 6 0 (0) 4 0 (0) 2 0 (0)
5 12 3 (25) 10 2 (20) 2 1 (50)
6 8 2 (25) 4 1 (25) 4 1 (25)
7 20 5 (25) 6 3 (50) 14 2 (14)
8 10 1 (10) 6 0 (0) 4 1 (25)
9 21 4 (19) 10 2 (20) 11 2 (18)
10 15 2 (13) 8 1 (13) 7 1 (14)
11 10 3 (30) 6 2 (33) 4 1 (25)
12 15 5 (33) 4 2 (50) 11 3 (27)
13 9 1 (11) 5 1 (20) 4 0 (0)
14 6 1 (17) 4 1 (25) 2 0 (0)
15 19 3 (16) 14 2 (14) 5 1 (20)
16 24 3 (13) 13 3 (23) 11 0 (0)
17 24 0 (0) 14 0 (0) 10 0 (0)
18 24 5 (21) 19 5 (26) 5 0 (0)
19 42 2 (5) 30 2 (7) 12 0 (0)
Total 289 46 (16) 169 31 (18) 120 15 (13)
Figure 4. Association between the percent of tamponade leading 
to surgery and center volume. The regression line demonstrates 
an inverse linear association: r=−0.466, R2=0.217, and P=0.04.
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CLINICAL PERSPECTIVE
Cardiac tamponade is the most dramatic complication observed during atrial fibrillation (AF) ablation and the leading cause 
of procedure-related mortality. Whether patient’s sex is associated with a different risk for developing this complication is 
unknown. This large worldwide multicenter study involving 34 943 AF ablation procedures was designed to answer this 
question. The occurrence of tamponade during AF ablation procedures was found to be relatively rare (0.84%); however, 
women had an 83% higher risk for developing this complication. The risk of developing tamponade was inversely related to 
center volume with a substantial decrease in women risk in high-volume centers. Surgical management was required in 16% 
of tamponade cases irrespectively of patient sex, whereas 1% of cases of tamponade resulted in death. To the best of our 
knowledge this is the largest study evaluating sex difference in the risk of tamponade during AF ablation. Center volume and 
patient sex should be taken in account when obtaining informed patient consent before the procedure. Also, surgical backup 
and acute management skills for treating tamponade are important in centers performing AF ablation. Additional research is 
needed to evaluate the potential role of other different covariates in the risk of tamponade that may likely be more frequently 
observed in women (ie, smaller left atrial size, heart size, and body mass index).
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Supplemental Table 1: Presumed mechanism of tamponade in 279 patients from 18 EP 
centers. 
All patients Males Females
Transseptal puncture 30 (10.8%) 11 (6.7%) 19 (16.3%)
Catheter manipulation 64 (22.9%) 35 (21.5%) 29 (25%)
During ablation 93 (33.3%) 59 (36.2%) 34 (29.3%)
Unknown 92 (32.9%) 58 (35.6%) 34 (29.3%)
Total 279 163 116
P=0.046
